ViroGates A/S 147,00
ViroGates A/S, a medical technology company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the suPAR (soluble urokinase plasminogen activator receptor) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex to help triage patients in the emergency setting and COVID-19 patients. In addition, its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was founded in 2000 and is headquartered in Birkerød, Denmark. ViroGates A/S was formerly a subsidiary of Medicon Valley. Læs mere
Kr. 395M Markedsværdi
Kr. 7,4M Omsætning
Medicinprodukter Industri
Danmark Hjemland Hjemmeside